Announcements Trials
Browse Landscape

Phase

Phase 2 39Phase 1 31Phase NA 23Phase 1/2 17Phase 3 11Phase EARLY_PHASE1 2Phase 4 2Phase 2/3 1

Status

Unknown 9Completed 9Terminated 2Recruiting 2Active not recruiting 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Head & Neck 1

Conditions

Breast Neoplasms 15Glioblastoma 14Neoplasms 12Melanoma 11Brain Neoplasms 11Head and Neck Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Pancreatic Neoplasms 9Lung Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Prostatic Neoplasms 8Glioma 8Ovarian Neoplasms 7Neoplasm Metastasis 7Lymphoma 6Colonic Neoplasms 6Multiple Myeloma 5Carcinoma, Hepatocellular 5Urinary Bladder Neoplasms 4Sarcoma 4Rectal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell 4Lymphoma, Large B-Cell, Diffuse 4Hodgkin Disease 4Stomach Neoplasms 3Recurrence 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Leukemia, Myeloid, Acute 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Terminated × Uterine Cervical Neoplasms × Clear all
NCT04630353 2025-09-12

A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer

Hookipa Biotech GmbH

Phase EARLY_PHASE1 Terminated
10 enrolled
GynecologicHead & Neck

Uterine Cervical Neoplasms, Oropharyngeal Neoplasms

NCT04476251 2021-12-15

E7 TCR T Cell Induction Immunotherapy for Stage IIB-IVA Cervical Cancer

National Institutes of Health Clinical Center (CC)

Phase EARLY_PHASE1 Terminated
1 enrolled 6 charts
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡